Clinical remission in adults with moderate-to-severe asthma
Journal session:
The Lancet Respiratory Medicine session
State-of-the-art insights into prevention, development and management of asthma
A new Lancet Respiratory Medicine Series paper places Danish research leadership in the spotlight. Professor Celeste Porsbjerg (Bispebjerg University Hospital, Copenhagen) and colleagues present a conceptual framework for remission in severe asthma that moves beyond symptoms and lung function, towards a biological definition of disease stability.
Introducing “At-Risk Asthma”
The authors introduce the concept of “at-risk asthma” – a phase marked by high disease activity and early remodelling, where timely treatment can still alter the disease trajectory. By intervening before irreversible damage occurs, clinicians may improve long-term outcomes and prevent progression to fixed airway obstruction and comorbidity-driven symptoms.
Key insight from the paper:
- Four central domains underpin asthma pathology:
- airway hyper-responsiveness
- airway immune hyper-responsiveness
- immune remodelling
- structural remodelling.
- A domain-based assessment strategy may help clinicians disentangle symptoms caused by active disease from those due to irreversible damage or comorbidities, enabling more personalised care.
- Timely, mechanism-based intervention during early disease stages offers the best chance for remission, while later structural changes are often resistant to therapy.
Ontime treatment shape long term outcomes
This biologically grounded framework reframes remission not as the absence of symptoms, but as the suppression of active disease biology. It also reinforces the central role of on-time treatment decisions in shaping long-term disease outcomes.
Read the full article here: The Lancet Respiratory Medicine, Sept 29, 2025
Nicolai Krogh
Medical Advisor Primary care
ID 17084-06.10.2025
For att se inholdet, skal du logge ind, For att se inholdet, skal du logge ind. For att se inholdet…
For att se inholdet, skal du logge ind, For att se inholdet, skal du logge ind Læs mere
Act before damage occurs – early disease in COPD
Some get off to a bad start, others simply do not realize they have a disease. And others fall into the trap of thinking that tobacco exposure could be too low to cause harm. Either way, to identify and treat persons living with COPD early in their disease is intriguing- and possible. Læs mere
Asthma comorbidities
In summary: Asthma is a complex disease worsened by comorbidities like CRSwNP, GERD, OSA, and obesity, which share inflammatory pathways and reduce treatment effectiveness. Obesity, in particular, exacerbates airway inflammation and poor asthma control. A treatable traits approach and multidisciplinary care can improve outcomes by targeting both pulmonary and non-pulmonary factors. Læs mere